Conway, J.W.; Braden, J.; Lo, S.N.; Scolyer, R.A.; Carlino, M.S.; Menzies, A.M.; Long, G.V.; Silva, I.P.d.
VEGF Inhibitors Improve Survival Outcomes in Patients with Liver Metastases across Cancer Types—A Meta-Analysis. Cancers 2023, 15, 5012.
https://doi.org/10.3390/cancers15205012
AMA Style
Conway JW, Braden J, Lo SN, Scolyer RA, Carlino MS, Menzies AM, Long GV, Silva IPd.
VEGF Inhibitors Improve Survival Outcomes in Patients with Liver Metastases across Cancer Types—A Meta-Analysis. Cancers. 2023; 15(20):5012.
https://doi.org/10.3390/cancers15205012
Chicago/Turabian Style
Conway, Jordan W., Jorja Braden, Serigne N. Lo, Richard A. Scolyer, Matteo S. Carlino, Alexander M. Menzies, Georgina V. Long, and Ines Pires da Silva.
2023. "VEGF Inhibitors Improve Survival Outcomes in Patients with Liver Metastases across Cancer Types—A Meta-Analysis" Cancers 15, no. 20: 5012.
https://doi.org/10.3390/cancers15205012
APA Style
Conway, J. W., Braden, J., Lo, S. N., Scolyer, R. A., Carlino, M. S., Menzies, A. M., Long, G. V., & Silva, I. P. d.
(2023). VEGF Inhibitors Improve Survival Outcomes in Patients with Liver Metastases across Cancer Types—A Meta-Analysis. Cancers, 15(20), 5012.
https://doi.org/10.3390/cancers15205012